![Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cancer | Future Science OA Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cancer | Future Science OA](https://www.future-science.com/cms/10.4155/fsoa-2016-0040/asset/images/medium/figure1.gif)
Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cancer | Future Science OA
![The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0304419X21001323-gr2.jpg)
The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect
![CA 72-4 marker: adjunct to conventional biomarkers in monitoring of pancreatic, ovarian and colorectal cancers. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc. CA 72-4 marker: adjunct to conventional biomarkers in monitoring of pancreatic, ovarian and colorectal cancers. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc.](https://www.advimmuno.com/wp-content/uploads/2019/04/CA72-4.jpeg)
CA 72-4 marker: adjunct to conventional biomarkers in monitoring of pancreatic, ovarian and colorectal cancers. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc.
![Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients | Anticancer Research Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/3/1691/F1.large.jpg)
Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients | Anticancer Research
![Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study](https://pub.mdpi-res.com/cancers/cancers-11-00733/article_deploy/html/images/cancers-11-00733-g001-550.jpg?1571594573)
Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0304419X21001323-gr1.jpg)
The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect
![Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer | Semantic Scholar Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/895971fec3a1231c762fbc95d48807da16a4ad85/5-TableVI-1.png)
Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer | Semantic Scholar
![Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer | Semantic Scholar Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/895971fec3a1231c762fbc95d48807da16a4ad85/4-TableIV-1.png)
Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer | Semantic Scholar
![Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer | BMC Cancer | Full Text Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-13-543/MediaObjects/12885_2012_Article_4161_Fig1_HTML.jpg)
Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer | BMC Cancer | Full Text
![Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and](https://cyberleninka.org/viewer_images/479802/f/1.png)